3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Vitamin D Deficiency
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycystic Ovary Syndrome
2
Vitamin D3
1
Prostatic Neoplasms
1
Pathologic Processes
1
Pain
1
Neuroma
1
Musculoskeletal Diseases
1
Multiple Sclerosis, Relapsing-Remitting
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Insulin Resistance
1
Infertility, Female
1
Hematologic Neoplasms
1
Glioblastoma
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Cancer Pain
1
Cachexia
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
17
Rituximab
12
Prednisone
7
Peripheral Blood Stem Cell Transplantation
7
Filgrastim
7
sargramostim
6
Vincristine
6
fludarabine phosphate
5
Radiotherapy
5
Doxorubicin
5
Cytarabine
5
Cisplatin
5
ibritumomab tiuxetan
4
Methylprednisolone
4
Melphalan
4
Etoposide
4
Dexamethasone
4
Cyclosporine
4
epratuzumab
3
Sensitivity and Specificity
3
Polymerase Chain Reaction
3
Mycophenolic Acid
3
Indium
3
Chlorambucil
3
Busulfan
3
Bendamustine Hydrochloride
3
Antilymphocyte Serum
3
Antigens, CD19
3
obinutuzumab
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Follicular
×
Cholecalciferol
×
Clear all
NCT05018988
2021-08-24
DVinCHI
University of Ulster
Phase NA
Unknown
118 enrolled